Rockefeller Capital Management L.P. Pfizer Inc Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 1,630,089 shares of PFE stock, worth $43.1 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

1,630,089

Previous 1,597,565 2.04%

Holding current value

$43.1 Million

Previous $44.7 Million 5.54%

% of portfolio

0.13%

Previous 0.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $900,914 - $1.02 Million	32,524 Added 2.04%	1,630,089 $47.2 Million
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $3.37 Million - $3.95 Million	-133,551 Reduced 7.71%	1,597,565 $44.7 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $13.4 Million - $15.4 Million	-517,866 Reduced 23.03%	1,731,116 $48 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.15 Million - $1.49 Million	43,846 Added 1.99%	2,248,982 $64.7 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $3.89 Million - $4.54 Million	121,124 Added 5.81%	2,205,136 $73.1 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $3.01 Million - $3.48 Million	83,329 Added 4.17%	2,084,012 $76.4 Million
Q1 2023 May 17, 2023	SELL	$39.39 - $51.28 $2.36 Million - $3.07 Million	-59,831 Reduced 2.9%	2,000,683 $81.6 Million
Q4 2022 Mar 06, 2023	BUY	$41.75 - $54.5 $22.9 Million - $29.9 Million	547,851 Added 36.22%	2,060,514 $106 Million
Q3 2022 Nov 02, 2022	BUY	$43.76 - $53.42 $3.59 Million - $4.38 Million	82,082 Added 5.74%	1,512,663 $66.2 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $7.42 Million - $8.8 Million	159,498 Added 12.55%	1,430,581 $75 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $5.65 Million - $7 Million	123,492 Added 10.76%	1,271,083 $65.8 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $1.09 Million - $1.61 Million	26,269 Added 2.34%	1,147,591 $67.8 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $5.54 Million - $7.11 Million	141,066 Added 14.39%	1,121,322 $48.2 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $3.63 Million - $4.11 Million	101,059 Added 11.49%	980,256 $38.4 Million
Q1 2021 May 11, 2021	SELL	$33.49 - $37.77 $512,865 - $578,409	-15,314 Reduced 1.71%	879,197 $31.9 Million
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $5.05 Million - $6.42 Million	150,834 Added 20.28%	894,511 $32.9 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $2.17 Million - $2.55 Million	68,483 Added 10.14%	743,677 $27.3 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $2.7 Million - $3.27 Million	-89,540 Reduced 11.71%	675,194 $22.1 Million
Q1 2020 May 12, 2020	BUY	$27.03 - $38.62 $6.78 Million - $9.69 Million	250,796 Added 48.8%	764,734 $25 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $3.25 Million - $3.69 Million	98,770 Added 23.79%	513,938 $20.1 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $3.89 Million - $5.04 Million	119,612 Added 40.47%	415,168 $14.9 Million
Q2 2019 Aug 09, 2019	BUY	$36.98 - $41.52 $836,524 - $939,223	22,621 Added 8.29%	295,556 $12.8 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $4.41 Million - $4.85 Million	117,609 Added 75.72%	272,935 $11.6 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $1.31 Million - $1.49 Million	34,080 Added 28.11%	155,326 $6.78 Million
Q3 2018 Nov 02, 2018	BUY	$34.47 - $41.81 $296,855 - $360,067	8,612 Added 7.65%	121,246 $5.34 Million
Q2 2018 Jul 31, 2018	SELL	$32.98 - $35.16 $484,937 - $516,992	-14,704 Reduced 11.55%	112,634 $4.09 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $4.06 Million - $4.71 Million	127,338 New	127,338 $4.52 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Pfizer Inc Transaction History